Skip to main content
Clinical Trials/DRKS00011342
DRKS00011342
Completed
Not Applicable

Multicentric retrospective prognostic evaluation of tumor volumes and their alteration in the curative-intended radiotherapy of the locally advanced NSCLC

Klinik für Strahlentherapie und Radioonkologie Halle0 sites346 target enrollmentNovember 24, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C34
Sponsor
Klinik für Strahlentherapie und Radioonkologie Halle
Enrollment
346
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 24, 2016
End Date
July 1, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Strahlentherapie und Radioonkologie Halle

Eligibility Criteria

Inclusion Criteria

  • histologically confirmed NSCLC (Adeno / PLECA) stage UICC III A or B
  • Age\> \= 18 years
  • complete curative\-intended radiotherapy (± chemotherapy), normofraction (achieved total dose \=60 Gy) or hypofraction (\=50 Gy)

Exclusion Criteria

  • Stereotactic radiotherapy
  • Second malignancy \<5 years before diagnosis of NSCLC
  • Pleural effusion, extensive atelectasis
  • Neoadjuvant chemotherapy before RT

Outcomes

Primary Outcomes

Not specified

Similar Trials